Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 15/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.43 |
| ▸ | PI4KA | P42356 | 1/20 | 0.43 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.43 |
| ▸ | F9 | P00740 | 2/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24619537 | 1.00 | LIMK1 (0.54) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL755297 | 1.00 | LIMK1 (0.54) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL18470285 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL18470271 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL26525944 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL23555984 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL1230128 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL23555670 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL18429798 | 0.96 | LIMK1 (0.57) | LIMK1PIK3CAPI4KAPI4KBF9 | |
| SCHEMBL18470300 | 0.92 | LIMK1 (0.51) | LIMK1PIK3CAPI4KAPI4KBF9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230207598-A1 | PHOTOELECTRIC CONVERTER AND IMAGING DEVICE | Sony Group Corporation (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230207598-A1 | PHOTOELECTRIC CONVERTER AND IMAGING DEVICE | Sony Group Corporation (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20220223802-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE | Sony Group Corporation (JP) | 2022-07-14 | — | — | US | disclosed |
| US-20220181568-A1 | SOLID-STATE IMAGING ELEMENT, METHOD FOR MANUFACTURING SOLID-STATE IMAGING ELEMENT, PHOTOELECTRIC CONVERSION ELEMENT, IMAGING DEVICE, AND ELECTRONIC APPARATUS | Sony Group Corporation (JP) | 2022-06-09 | — | — | US | disclosed |
| US-8138355-B2 | Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same | TOSOH CORPORATION (JP) | 2012-03-20 | — | — | US | disclosed |
| US-8138355-B2 | Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same | TOSOH CORPORATION (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20090261300-A1 | HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME | TOSOH CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090261300-A1 | HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME | TOSOH CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090261300-A1 | HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME | AS3MT, TERT, TEAD1 | LIMK1 823/4885PIK3CA 1767/4885PI4KA 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.